{
    "nctId": "NCT02292407",
    "briefTitle": "Prospective Pilot Study ANDPrecise",
    "officialTitle": "AND Precise! : Axillary Lymph Node Dissection and No Drain With the PRECISE Instrument",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE3",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 20,
    "primaryOutcomeMeasure": "Number of seroma evacuations per patient",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Indications for axillary clearance can be a tumor positive sentinel node or tumor positive lymph nodes proven by ultrasound or fine needle aspiration cytology.\n* For this pilot, only patients undergoing breast conserving surgery are eligible.\n* Axillary clearance can be performed after previous sentinel node procedure, at the same operation, and after neo-adjuvant chemo therapy, and as secondary procedure in case of axillary relapse after previous treatment for breast cancer.\n\nExclusion Criteria:\n\n* Patients undergoing a modified radical mastectomy including an axillary clearance.\n* Preoperative preexisting seroma.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}